Literature DB >> 11184857

Ethics consultation: is it enough to mean well?

M P Aulisio1.   

Abstract

Keywords:  Bioethics and Professional Ethics; Professional Patient Relationship

Mesh:

Year:  1999        PMID: 11184857     DOI: 10.1023/a:1008945430160

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


× No keyword cloud information.
  8 in total

1.  Patient decision-making capacity and risk.

Authors:  Mark R Wicclair
Journal:  Bioethics       Date:  1991-04       Impact factor: 1.898

2.  Obstacles and opportunities in the design of ethics consultation evaluation.

Authors:  J A Tulsky; C B Stocking
Journal:  J Clin Ethics       Date:  1996

3.  Evaluation research and the future of ethics consultation.

Authors:  E Fox; J A Tulsky
Journal:  J Clin Ethics       Date:  1996

4.  Concepts in evaluation applied to ethics consultation research.

Authors:  E Fox
Journal:  J Clin Ethics       Date:  1996

Review 5.  Evaluating outcomes in ethics consultation research.

Authors:  E Fox; R M Arnold
Journal:  J Clin Ethics       Date:  1996

Review 6.  Evaluating ethics consultation: framing the questions.

Authors:  J A Tulsky; E Fox
Journal:  J Clin Ethics       Date:  1996

7.  Reassessing the reliability of advance directives.

Authors:  T May
Journal:  Camb Q Healthc Ethics       Date:  1997       Impact factor: 1.284

8.  The many faces of competency.

Authors:  J F Drane
Journal:  Hastings Cent Rep       Date:  1985-04       Impact factor: 2.683

  8 in total
  4 in total

1.  Corporate ethics in the life sciences: can bioethics help? Should it?

Authors:  Chris MacDonald
Journal:  HEC Forum       Date:  2005-06

2.  HEC member perspectives on the case analysis process: a qualitative multi-site study.

Authors:  Eric Racine
Journal:  HEC Forum       Date:  2007-09

3.  Conceptualizing boundaries for the professionalization of healthcare ethics practice: a call for empirical research.

Authors:  Nancy C Brown; Summer Johnson McGee
Journal:  HEC Forum       Date:  2014-12

Review 4.  Ethical challenges in end-of-life therapies in the elderly.

Authors:  Michael Gordon
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.